Global

Servier’s $2.65B Muscular Dystrophy Deal Turns Rare Neurology Into a Commercial Priority

Alzheimer’s Blood Testing Moves the Disease Clock Earlier

Lenacapavir Turns HIV Prevention Into an Access Stress Test

WHO’s New AMR Plan Makes Stewardship and Access a Single Test

Physical activity continues to strengthen its case as a cross-disease prevention strategy

The Air We Breathe May Be Shaping the Future Burden of Blindness

Ozempic and Eye Health: Balancing Metabolic Benefits with Vision Risks

An ADC Steps Into the First-Line Gap in Triple-Negative Breast Cancer

Hepatitis B Functional Cure Moves Closer, But Access Still Starts With Diagnosis
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
